NSB.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 01:50):

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies...

Stats
Today's Volume	188 602
Average Volume	717 164
Market Cap	7.66M
EPS	$0 ( 2024-02-25 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	5.30
ATR14	$0 (0.00%)

NeuroScientific Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

NeuroScientific Financials

Annual	2023
Revenue:	$4.95M
Gross Profit:	$4.90M (98.83 %)
EPS:	$-0.00740

Q2	2023
Revenue:	$0
Gross Profit:	$-42 431.00 (0.00 %)
EPS:	$-0.00850

Q4	2023
Revenue:	$3.79M
Gross Profit:	$3.77M (99.27 %)
EPS:	$0.0139

Q3	2022
Revenue:	$1.90M
Gross Profit:	$1.87M (98.79 %)
EPS:	$0.00690

Financial Reports:

No articles found.

NeuroScientific

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.